Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Rein Therapeutics (RNTX) Return on Assets (2017 - 2025)

Rein Therapeutics filings provide 9 years of Return on Assets readings, the most recent being 0.27% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets fell 11.0% year-over-year to 0.27%, compared with a TTM value of 0.27% through Dec 2025, down 11.0%, and an annual FY2025 reading of 0.23%, down 7.0% over the prior year.
  • Return on Assets hit 0.27% in Q4 2025 for Rein Therapeutics, down from 0.16% in the prior quarter.
  • The five-year high for Return on Assets was 0.16% in Q4 2024, with the low at 1.23% in Q1 2023.
  • Median Return on Assets over the past 5 years was 0.38% (2021), compared with a mean of 0.53%.
  • The sharpest move saw Return on Assets crashed -60bps in 2022, then surged 105bps in 2024.
  • Year by year, Return on Assets stood at 0.51% in 2021, then plummeted by -117bps to 1.12% in 2022, then surged by 76bps to 0.27% in 2023, then skyrocketed by 40bps to 0.16% in 2024, then crashed by -68bps to 0.27% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.27%, 0.16%, and 0.17% for Q4 2025, Q3 2025, and Q2 2025 respectively.